Variant report
Variant | nsv432499 |
---|---|
Chromosome Location | chr3:163662298-163705731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163674728..163675758-chr3:164903457..164904093,3 | MCF-7 | breast: | |
2 | chr3:163639924..163641654-chr3:163663861..163665823,2 | MCF-7 | breast: | |
3 | chr3:163634067..163635345-chr3:163668973..163669822,4 | MCF-7 | breast: | |
4 | chr3:163689823..163692046-chr3:163703767..163706359,2 | K562 | blood: | |
5 | chr3:163689823..163692046-chr3:163703767..163706359,2 | K562 | blood: | |
6 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: | |
7 | chr3:163676571..163679360-chr3:163699055..163700602,2 | MCF-7 | breast: | |
8 | chr3:163664276..163666199-chr3:163667456..163669439,2 | MCF-7 | breast: | |
9 | chr3:163674674..163675466-chr3:164524045..164524647,3 | MCF-7 | breast: | |
10 | chr3:163676571..163679360-chr3:163699055..163700602,2 | MCF-7 | breast: | |
11 | chr3:163664276..163666199-chr3:163667456..163669439,2 | MCF-7 | breast: | |
12 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: | |
13 | chr3:163669046..163669790-chr3:164903266..164903861,2 | MCF-7 | breast: | |
14 | chr3:163497409..163497997-chr3:163668939..163669921,2 | MCF-7 | breast: | |
15 | chr3:163219408..163221189-chr3:163663438..163665910,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574219170 | chr3:163670448-163670449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184283632 | chr3:163670510-163670511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs80013016 | chr3:163670527-163670528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141609789 | chr3:163670811-163670812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534881267 | chr3:163670813-163670814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7627722 | chr3:163670869-163670870 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs578197422 | chr3:163670887-163670888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574461898 | chr3:163670891-163670892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543470488 | chr3:163670935-163670936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369518729 | chr3:163670953-163670954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145365200 | chr3:163670965-163670966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532505181 | chr3:163670998-163670999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374782242 | chr3:163671015-163671016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552687568 | chr3:163671032-163671033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559977494 | chr3:163671037-163671038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9829001 | chr3:163671071-163671072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs548878755 | chr3:163671074-163671075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7627791 | chr3:163671095-163671096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537009461 | chr3:163671105-163671106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62284178 | chr3:163671106-163671107 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570472921 | chr3:163671108-163671109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539148792 | chr3:163671145-163671146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201827503 | chr3:163671148-163671149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572677101 | chr3:163671164-163671165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535285943 | chr3:163671169-163671170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7630165 | chr3:163671174-163671175 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs374134496 | chr3:163671178-163671179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563531438 | chr3:163671202-163671203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577209341 | chr3:163671203-163671204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7630237 | chr3:163671228-163671229 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs561210153 | chr3:163671239-163671240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11710022 | chr3:163671259-163671260 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs528669346 | chr3:163671290-163671291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551253872 | chr3:163671319-163671320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188896567 | chr3:163671322-163671323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112401967 | chr3:163671330-163671331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9829413 | chr3:163671341-163671342 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs562321337 | chr3:163671355-163671356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs193252157 | chr3:163671358-163671359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9829526 | chr3:163671367-163671368 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs550849749 | chr3:163671384-163671385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539444989 | chr3:163671388-163671389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184525063 | chr3:163671439-163671440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370808372 | chr3:163671442-163671443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566243053 | chr3:163671477-163671478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149518015 | chr3:163671493-163671494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555149265 | chr3:163671516-163671517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73166457 | chr3:163671540-163671541 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs537742638 | chr3:163671549-163671550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9830106 | chr3:163671569-163671570 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163670400-163670600 | Enhancers | Pancreas | Pancrea |
2 | chr3:163670800-163671200 | Weak transcription | Pancreas | Pancrea |
3 | chr3:163671200-163671800 | Enhancers | Pancreas | Pancrea |
4 | chr3:163671600-163671800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr3:163671800-163684800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr3:163686000-163686400 | Active TSS | Gastric | stomach |
7 | chr3:163686200-163686600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |